https://www.bioworld.com/articles/496648-regulator
Post# of 144823
![Avatar](/images/ProfileImages/2085337120_63500_icons8-airport-96.png)
Announced it will submit requests for pre-submission meetings in the U.K. for leronlimab as an HIV treatment in combination with HAART for highly treatment-experienced HIV patients, as well as for emergency approval for COVID-19 patients with mild to moderate symptoms
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)